Gestational diabetes: Continuous glucose monitoring can reduce risk of excessive birth weight

An international research team led by the Medical University of Vienna has shown that continuous glucose monitoring (CGM) in women with gestational diabetes can reduce the risk of a newborn with above-average birth weight. The study, published in the journal The Lancet Diabetes & Endocrinology, is the first multicenter randomized controlled trial to demonstrate the advantages of the digital method over conventional self-monitoring of blood glucose using finger pricks and opens up new perspectives for the targeted care of women with gestational diabetes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup